Compare ELPC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ELPC | BAX |
|---|---|---|
| Founded | 1954 | 1931 |
| Country | Brazil | United States |
| Employees | 3129 | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.2B |
| IPO Year | N/A | 1994 |
| Metric | ELPC | BAX |
|---|---|---|
| Price | $12.38 | $17.46 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $21.00 |
| AVG Volume (30 Days) | 333.6K | ★ 7.2M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 5.53% | 0.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | N/A | $1.96 |
| Revenue Next Year | $12.11 | $2.22 |
| P/E Ratio | $77.44 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $7.32 | $15.73 |
| 52 Week High | $13.70 | $32.68 |
| Indicator | ELPC | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 44.97 | 49.19 |
| Support Level | $12.36 | $15.95 |
| Resistance Level | $13.70 | $17.50 |
| Average True Range (ATR) | 0.31 | 0.73 |
| MACD | -0.14 | -0.09 |
| Stochastic Oscillator | 4.11 | 43.78 |
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power Sale, Services, and Holding. The majority of its revenue is generated from the Power distribution segment under which it provides public electricity distribution services, being responsible for the operation and maintenance of the distribution infrastructure, as well as providing related services.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.